Paula Marincola Smith1, Jordan Baechle2, Carmen C Solórzano1, Marcus Tan1, Alexandra G Lopez-Aguiar3, Mary Dillhoff4, Eliza Beal4, George Poultsides5, John G D Cannon5, Flavio G Rocha6, Angelena Crown6, Clifford Cho7, Megan Beems7, Emily R Winslow8, Victoria R Rendell8, Bradley A Krasnick9, Ryan C Fields9, Shishir K Maithel3, Christina E Bailey1, Kamran Idrees10. 1. Division of Surgical Oncology, Department of Surgery, Section of Surgical Sciences, Vanderbilt University Medical Center, Nashville, TN, USA. 2. Meharry Medical College, Nashville, TN, USA. 3. Division of Surgical Oncology, Department of Surgery, Winship Cancer Institute, Emory University, Atlanta, GA, USA. 4. Division of Surgical Oncology, The Ohio State University Comprehensive Cancer Center, Columbus, OH, USA. 5. Department of Surgery, Stanford University Medical Center, Stanford, CA, USA. 6. Department of Surgery, Virginia Mason Medical Center, Seattle, WA, USA. 7. Division of Hepatopancreatobiliary and Advanced Gastrointestinal Surgery, Department of Surgery, University of Michigan, Ann Arbor, MI, USA. 8. Department of Surgery, University of Wisconsin School of Medicine and Public Health, Madison, WI, USA. 9. Department of Surgery, Washington University School of Medicine, St Louis, MO, USA. 10. Division of Surgical Oncology, Department of Surgery, Section of Surgical Sciences, Vanderbilt University Medical Center, Nashville, TN, USA. Electronic address: kamran.idrees@vumc.org.
Abstract
BACKGROUND: Packed red blood cell (PRBC) transfusion has been associated with worse survival in multiple malignancies but its impact on pancreatic neuroendocrine tumors (PNETs) is unknown. The aim of this study was to determine the impact of PRBC transfusion on survival following PNET resection. METHODS: A retrospective cohort study of PNET patients was performed using the US Neuroendocrine Tumor Study Group database. Demographic and clinical factors were compared. Kaplan-Meier and log-rank analyses were performed. Factors associated with transfusion, overall (OS), recurrence-free (RFS) and progression-free survival (PFS) were assessed by logistic regression. RESULTS: Of 1129 patients with surgically resected PNETs, 156 (13.8%) received perioperative PRBC transfusion. Transfused patients had higher ASA Class, lower preoperative hemoglobin, larger tumors, more nodal involvement, and increased major complications (all p < 0.010). Transfused patients had worse median OS (116 vs 150 months, p < 0.001), worse RFS (83 vs 128 months, p < 0.01) in curatively resected (n = 1047), and worse PFS (11 vs 24 months, p = 0.110) in non-curatively resected (n = 82) patients. On multivariable analysis, transfusion was associated with worse OS (HR 1.80, p = 0.011) when controlling for TNM stage, tumor grade, final resection status, and pre-operative anemia. CONCLUSION: PRBC transfusion is associated with worse survival for patients undergoing PNET resection.
BACKGROUND: Packed red blood cell (PRBC) transfusion has been associated with worse survival in multiple malignancies but its impact on pancreatic neuroendocrine tumors (PNETs) is unknown. The aim of this study was to determine the impact of PRBC transfusion on survival following PNET resection. METHODS: A retrospective cohort study of PNET patients was performed using the US Neuroendocrine Tumor Study Group database. Demographic and clinical factors were compared. Kaplan-Meier and log-rank analyses were performed. Factors associated with transfusion, overall (OS), recurrence-free (RFS) and progression-free survival (PFS) were assessed by logistic regression. RESULTS: Of 1129 patients with surgically resected PNETs, 156 (13.8%) received perioperative PRBC transfusion. Transfused patients had higher ASA Class, lower preoperative hemoglobin, larger tumors, more nodal involvement, and increased major complications (all p < 0.010). Transfused patients had worse median OS (116 vs 150 months, p < 0.001), worse RFS (83 vs 128 months, p < 0.01) in curatively resected (n = 1047), and worse PFS (11 vs 24 months, p = 0.110) in non-curatively resected (n = 82) patients. On multivariable analysis, transfusion was associated with worse OS (HR 1.80, p = 0.011) when controlling for TNM stage, tumor grade, final resection status, and pre-operative anemia. CONCLUSION:PRBC transfusion is associated with worse survival for patients undergoing PNET resection.
Authors: K Oberg; L Kvols; M Caplin; G Delle Fave; W de Herder; G Rindi; P Ruszniewski; E A Woltering; B Wiedenmann Journal: Ann Oncol Date: 2004-06 Impact factor: 32.976
Authors: Matthias Reeh; Tarik Ghadban; Josephine Dedow; Eik Vettorazzi; Faik G Uzunoglu; Michael Nentwich; Stefan Kluge; Jakob R Izbicki; Yogesh K Vashist Journal: World J Surg Date: 2017-01 Impact factor: 3.352
Authors: Jeffrey L Carson; Brenda J Grossman; Steven Kleinman; Alan T Tinmouth; Marisa B Marques; Mark K Fung; John B Holcomb; Orieji Illoh; Lewis J Kaplan; Louis M Katz; Sunil V Rao; John D Roback; Aryeh Shander; Aaron A R Tobian; Robert Weinstein; Lisa Grace Swinton McLaughlin; Benjamin Djulbegovic Journal: Ann Intern Med Date: 2012-07-03 Impact factor: 25.391
Authors: Brian J Linder; Igor Frank; John C Cheville; Matthew K Tollefson; R Houston Thompson; Robert F Tarrell; Prabin Thapa; Stephen A Boorjian Journal: Eur Urol Date: 2013-01-11 Impact factor: 20.096